These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33972378)

  • 1. Cell-free expression of the outer membrane protein OprF of
    Mayeux G; Gayet L; Liguori L; Odier M; Martin DK; Cortès S; Schaack B; Lenormand JL
    Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33972378
    [No Abstract]   [Full Text] [Related]  

  • 2. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Lu H; Kock ND; Wozniak DJ; Mizel SB
    Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R; El-Naggar W; Abd El-Aziz AM; Shaaban M; Kenawy HI; Ali YM
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii.
    Bahey-El-Din M; Mohamed SA; Sheweita SA; Haroun M; Zaghloul TI
    Int J Med Microbiol; 2020 Apr; 310(3):151415. PubMed ID: 32156509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers.
    Westritschnig K; Hochreiter R; Wallner G; Firbas C; Schwameis M; Jilma B
    Hum Vaccin Immunother; 2014; 10(1):170-83. PubMed ID: 24064511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant hybrid outer membrane protein for vaccination against Pseudomonas aeruginosa.
    Knapp B; Hundt E; Lenz U; Hungerer KD; Gabelsberger J; Domdey H; Mansouri E; Li Y; von Specht BU
    Vaccine; 1999 Mar; 17(13-14):1663-6. PubMed ID: 10194820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
    Kaloshin AA; Mikhaĭlova NA; Leonova EI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (3):35-43. PubMed ID: 22830272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 10. OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa.
    Ding B; von Specht BU; Li Y
    Vaccine; 2010 Jun; 28(25):4119-22. PubMed ID: 20433804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of recombinant Bb(pGEX-OprF-I) vaccine of Pseudomonas aeruginosa and its protection elicited in mice].
    Liang C; Li W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jul; 35(7):589-594. PubMed ID: 31537242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of immunogenic properties of recombinant outer membrane proteins F and L from Pseudomonas aeruginosa].
    Kaloshin AA; Zlygostev SA; Gatypova EV; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (5):76-9. PubMed ID: 19004286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of food-grade inducible expression system in Lactococcus lactis and expression of fusion OprF/H from Pseudomonas aeruginosa].
    Xu B; Cao YS; Chen Y; Guo XH
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):604-9. PubMed ID: 17944358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice.
    Yu X; Wang Y; Xia Y; Zhang L; Yang Q; Lei J
    Vaccine; 2016 Aug; 34(37):4399-405. PubMed ID: 27449680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa.
    Solanki V; Tiwari M; Tiwari V
    Sci Rep; 2019 Mar; 9(1):5240. PubMed ID: 30918289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.
    Peluso L; de Luca C; Bozza S; Leonardi A; Giovannini G; Lavorgna A; De Rosa G; Mascolo M; Ortega De Luna L; Catania MR; Romani L; Rossano F
    BMC Microbiol; 2010 Jan; 10():9. PubMed ID: 20070893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.
    Weimer ET; Ervin SE; Wozniak DJ; Mizel SB
    Vaccine; 2009 Nov; 27(48):6762-9. PubMed ID: 19744586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pushing beyond the Envelope: the Potential Roles of OprF in
    Cassin EK; Tseng BS
    J Bacteriol; 2019 Sep; 201(18):. PubMed ID: 31010902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.